In one year, ERI Scientific Beta has seen its assets under replication grow by 60%
ERI Scientific Beta, the smart beta index provider offshoot of EDHEC Risk Institute, has announced that assets tracking its smart beta indices had reached USD 16.46bn at June 30, 2017. In terms of geographical distribution, these assets come from North America (51%), Europe (46%) and Asia-Pacific (3%).
Compared to June 30, 2016, this amount of assets under replication represents growth of 60%.
An important driver of the growth in assets replicating Scientific Beta indices is live performance. The first generation Scientific Beta multi-smart-factor indices created in 2013 have a live track record for over 3 years that shows annualised outperformance of 2.20%1.
Commenting on the announcement Noël Amenc, CEO of ERI Scientific Beta, said, "Scientific Beta's success over the past four years is due in no small part to the fact that its investment philosophy has proven attractive to major institutional investors throughout the world. This investment philosophy is based on three major principles: the importance of controlling the risks of the investment, because the alternative choice to the cap-weighted index means that one takes different risks, and these risks must be controlled; the essential diversification of the specific risks of the benchmark to produce robust risk-adjusted performance and avoid good long-term investment ideas being called into question by poor short-term performance due to poor diversification; and the concern for robustness, which implies that the design of an index must rely on academic consensus and not on innovations drawn from optimising the returns or the in-sample characteristics of the strategy proposed."
1The average live outperformance across all Scientific Beta developed regions of Scientific Beta Multi-Beta Multi-Strategy (Equal Weight and Equal Risk Contribution) indices is 2.19% and 2.21%. This live analysis is based on daily total returns in the period from December 20, 2013 (live date) to June 30, 2017 for all diversified multi-strategy indices that have more than 3 years of track record for all available developed world regions - USA, Eurozone, UK, Developed Europe, Developed Europe ex UK, Japan, Developed Asia Pacific ex Japan, Developed ex UK, Developed ex USA and Developed. The benchmark used is a cap-weighted portfolio of all stocks in the respective Scientific Beta universes.
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #15-02, Singapore 049145. For further information, please contact: E-mail: [email protected], Web: www.scientificbeta.com.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/7daf51ee-dabb-46bc-b6b2-9c6c7f243891


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



